Peter Cherepanov
Impact in
- Virology top 0.05%
- HIV Research and Treatment
- Infectious Diseases top 0.1%
- HIV/AIDS drug development and treatment
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Virology 67
- HIV Research and Treatment 67
-
- HIV/AIDS drug development and treatment 56
- SARS-CoV-2 and COVID-19 Research 22
- COVID-19 Clinical Research Studies 13
- Co-authors
- Alan Engelman (41 shared papers)Wilfried Wackernagel (2 shared papers)S. Hare (16 shared papers)Goedele N. Maertens (15 shared papers)Zeger Debyser (18 shared papers)Erik De Clercq (17 shared papers)Saumya Shree Gupta (5 shared papers)Eugene Valkov (3 shared papers)
- Journals
- Nucleic Acids Research (8 papers)Nature Communications (8 papers)PLoS Pathogens (6 papers)Journal of Biological Chemistry (6 papers)Nature (6 papers)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Peter Cherepanov
129 papers receiving 12.0k citations
Peter Cherepanov's Hit Papers
Peers
Comparison fields: 5 of 143
- Virology 4.9k
- Infectious Diseases 6.4k
- Endocrinology 502
- Molecular Biology 6.5k
- Genetics 2.2k
Countries citing papers authored by Peter Cherepanov
This map shows the geographic impact of Peter Cherepanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Cherepanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Cherepanov more than expected).
Fields of papers citing papers by Peter Cherepanov
This network shows the impact of papers produced by Peter Cherepanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Cherepanov. The network helps show where Peter Cherepanov may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Cherepanov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant Hit paper breakdown → | 1995 | 1601 |
| 2 | Preexisting and de novo humoral immunity to SARS-CoV-2 in humans Hit paper breakdown → | 2020 | 642 |
| 3 | Retroviral intasome assembly and inhibition of DNA strand transfer Hit paper breakdown → | 2010 | 573 |
| 4 | 2002 | 571 | |
| 5 | 2003 | 417 | |
| 6 | 2005 | 345 | |
| 7 | 2012 | 282 | |
| 8 | 2010 | 260 | |
| 9 | 2002 | 257 | |
| 10 | 2010 | 255 | |
| 11 | 2004 | 242 | |
| 12 | 2011 | 222 | |
| 13 | 2005 | 197 | |
| 14 | 2008 | 191 | |
| 15 | 2016 | 173 | |
| 16 | 2010 | 170 | |
| 17 | 2021 | 166 | |
| 18 | 2020 | 155 | |
| 19 | 2009 | 145 | |
| 20 | 2006 | 143 |
About Peter Cherepanov
Peter Cherepanov is a scholar working on Virology, Infectious Diseases, Molecular Biology, Epidemiology and Genetics, having authored 131 papers that have together received 12.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (67 papers), HIV/AIDS drug development and treatment (56 papers), Biochemical and Molecular Research (33 papers), SARS-CoV-2 and COVID-19 Research (22 papers), CRISPR and Genetic Engineering (17 papers), Cytomegalovirus and herpesvirus research (15 papers), COVID-19 Clinical Research Studies (13 papers) and Virus-based gene therapy research (10 papers). The work is most often cited by research in Virology (4.9k citations), Infectious Diseases (6.4k citations), Endocrinology (502 citations), Molecular Biology (6.5k citations) and Genetics (2.2k citations). Peter Cherepanov has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Alan Engelman, Wilfried Wackernagel, S. Hare, Goedele N. Maertens, Zeger Debyser, Erik De Clercq, Saumya Shree Gupta, Eugene Valkov, Yves Engelborghs and Shaila Rahman. Their work appears in journals such as Nucleic Acids Research, Nature Communications, PLoS Pathogens, Journal of Biological Chemistry and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.